Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia

被引:62
作者
Gordeuk, Victor R. [1 ]
Minniti, Caterina R. [2 ]
Nouraie, Mehdi [1 ]
Campbell, Andrew D. [3 ]
Rana, Sohail R. [4 ]
Luchtman-Jones, Lori [5 ]
Sable, Craig [5 ]
Dham, Niti [5 ]
Ensing, Gregory [3 ]
Prchal, Josef T. [6 ,7 ]
Kato, Gregory J. [2 ]
Gladwin, Mark T. [8 ,9 ]
Castro, Oswaldo L. [1 ]
机构
[1] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20060 USA
[2] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[4] Howard Univ, Dept Pediat & Child Hlth, Washington, DC 20060 USA
[5] Childrens Natl Med Ctr, Washington, DC 20010 USA
[6] Univ Utah, Salt Lake City, UT USA
[7] ARUP, Salt Lake City, UT USA
[8] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA
[9] Univ Pittsburgh, Med Ctr, Vasc Med Inst, Pittsburgh, PA USA
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2011年 / 96卷 / 01期
基金
美国国家卫生研究院;
关键词
sickle cell anemia; tricuspid regurgitation velocity; E/Etdi; hemolysis; six minute walk; PULMONARY-ARTERY PRESSURES; RISK-FACTOR; TASK-FORCE; HYPERTENSION; DISEASE; DEATH; STANDARDS; HEMOLYSIS; ADULTS;
D O I
10.3324/haematol.2010.030767
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background While in adults with sickle cell disease an elevation of tricuspid regurgitation velocity is associated with increased mortality, the importance of this finding in children has not been established. The role of intravascular hemolysis in the development of this complication is controversial. Design and Methods We conducted a prospective, longitudinal, multi-center study of 160 individuals aged 3-20 years with hemoglobin SS, performing baseline and follow-up determinations of clinical markers, six-minute walk distance less than tricuspid regurgitation velocity and E/Etdi ratio by echocardiography. Results At baseline, 14.1% had tricuspid regurgitation velocity of 2.60 m/sec or over, which suggests elevated systolic pulmonary artery pressure, and 7.7% had increased E/Etdi, which suggests elevated left ventricular filling pressure. Over a median of 22 months, baseline elevation in tricuspid regurgitation velocity was associated with an estimated 4.4-fold increase in the odds of a 10% or more decline in age-standardized six-minute-walk distance (P=0.015). During this interval, baseline values above the median for a hemolytic component derived from four markers of hemolysis were associated with a 9.0-fold increase in the odds of the new onset of elevated tricuspid regurgitation velocity (P=0.008) and baseline E/Etdi elevation was associated with an estimated 6.1-fold increase in the odds (P=0.039). In pathway analysis, higher baseline hemolytic component and E/Etdi predicted elevated tricuspid regurgitation velocity at both baseline and follow up, and these elevations in turn predicted decline in six-minute-walk distance. Conclusions Further studies should define the long-term risks of elevated tricuspid regurgitation velocity in childhood and identify potential interventions to prevent increased pulmonary artery pressure and preserve function.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 43 条
  • [1] Cardiac involvement in thalassemia intermedia: a multicenter study
    Aessopos, A
    Farmakis, D
    Karagiorga, M
    Voskaridou, E
    Loutradi, A
    Hatziliami, A
    Joussef, J
    Rombos, J
    Loukopoulos, D
    [J]. BLOOD, 2001, 97 (11) : 3411 - 3416
  • [2] Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension
    Anthi, Anastasia
    Machado, Roberto F.
    Jison, Maria L.
    Taveira-DaSilva, Angelo M.
    Rubin, Lewis J.
    Hunter, Lori
    Hunter, Christian J.
    Coles, Wynona
    Nichols, James
    Avila, Nilo A.
    Sachdev, Vandana
    Chen, Clara C.
    Gladwin, Mark T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (12) : 1272 - 1279
  • [3] Pulmonary hypertension in patients with sickle cell disease: a longitudinal study
    Ataga, Kenneth I.
    Moore, Charity G.
    Jones, Susan
    Olajide, Oludamilola
    Strayhorn, Dell
    Hinderliter, Alan
    Orringer, Eugene P.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (01) : 109 - 115
  • [4] BACHIR D, 2009, AM SOC HEM ANN M NEW
  • [5] Pulmonary hypertension and nitric oxide depletion in sickle cell disease
    Bunn, H. Franklin
    Nathan, David G.
    Dover, George J.
    Hebbel, Robert P.
    Platt, Orah S.
    Rosse, Wendell F.
    Ware, Russell E.
    [J]. BLOOD, 2010, 116 (05) : 687 - 692
  • [6] Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients
    Campbell, Andrew
    Minniti, Caterina P.
    Nouraie, Mehdi
    Arteta, Manuel
    Rana, Sohail
    Onyekwere, Onyinye
    Sable, Craig
    Ensing, Gregory
    Dham, Niti
    Luchtman-Jones, Lori
    Kato, Gregory J.
    Gladwin, Mark T.
    Castro, Oswaldo L.
    Gordeuk, Victor R.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (03) : 352 - 359
  • [7] Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
    Castro, O
    Hoque, M
    Brown, BD
    [J]. BLOOD, 2003, 101 (04) : 1257 - 1261
  • [8] PULMONARY-HYPERTENSION AND COR-PULMONALE IN THE SICKLE HEMOGLOBINOPATHIES
    COLLINS, FS
    ORRINGER, EP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (06) : 814 - 821
  • [9] ATS statement: Guidelines for the six-minute walk test
    Crapo, RO
    Casaburi, R
    Coates, AL
    Enright, PL
    MacIntyre, NR
    McKay, RT
    Johnson, D
    Wanger, JS
    Zeballos, RJ
    Bittner, V
    Mottram, C
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) : 111 - 117
  • [10] Pulmonary Hypertension in Children and Young Adults With Sickle Cell Disease: Evidence for Familial Clustering
    Dahoui, Hanane A.
    Hayek, Munya N.
    Nietert, Paul J.
    Arabi, Mariam T.
    Muwakkit, Samar A.
    Saab, Raya H.
    Bissar, Abdallah N.
    Jumaa, Nidal M.
    Farhat, Fadi S.
    Dabbous, Ibrahim A.
    Bitar, Fadi F.
    Abboud, Miguel R.
    [J]. PEDIATRIC BLOOD & CANCER, 2010, 54 (03) : 398 - 402